Plasma concentrations of platelet-specific proteins in coronary artery disease

Cardiology (Switzerland)

Volumn 68, Issue 3, 1981, Pages 129-138

  Mühlhauser, Ingrid ^a   Schernthaner, Guntram ^a   Silberbauer, Karl ^a   Sinzinger, Helmut ^a   Kaindl, Fritz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aortocoronary bypass surgery; Coronary artery disease; Oral anticoagulants; Platelet factor 4; Blocking agents; Thromboglobulin

Indexed keywords

ADRENERGIC BETA ANTAGONISTS; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA GLOBULIN; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR; THROMBOCYTE FACTOR 4; ACENOCOUMAROL; METOPROLOL; OXPRENOLOL; PHENPROCOUMON; PINDOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; BLOOD AND HEMOPOIETIC SYSTEM; CORONARY ARTERY; DRUG BLOOD LEVEL; DRUG THERAPY; GREAT BLOOD VESSEL; HEART; ISCHEMIC HEART DISEASE; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY; THERAPY; THROMBOCYTE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTICOAGULANTS; BETA-GLOBULINS; BETA-THROMBOGLOBULIN; BLOOD COAGULATION FACTORS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; CORONARY DISEASE; EVALUATION STUDIES; FEMALE; HUMAN; MALE; MIDDLE AGE; PLATELET FACTOR 4;

EID: 0019393410     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000173274     Document Type: Article

References (33)

1. Steele. P.P.; Weily, H.S.; Davies, H.; Genton, E.: Platelet function studies in coronary artery disease. Circulation 48: 1194 (1973).
2. Salky. N.: Dugdale, M.: Platelet abnormalities in ischemic heart disease. Am. J. Car-diol. 32: 612 (1973).
3. Frishman. W.; Weksler, B.; Caristodoulou. J.; Smithen. C.; Killip, T.: Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol. Circulaiion 50: 887 (1974).
4. Foils, J.D.; Crowell, E.B.; Rowe, L.L.: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54: 365 (1976).
5. Ross, R.; Glomset. J.A.: The pathogenesis of atherosclerosis. New Engl. J. Med. 295: 369 (1976).
6. Bolton. A.E.: Ludlam, C.A.: Moore. S.; Pepper, D.S.; Cash. J.D.: Three approaches to the radioimmunoassay of human β-thromboglobulin. Br. J. Haemat. 32: 73 (1976).
7. Bolton. A.E.; Ludlam. C.A.: Pepper, D.S.: Moore, S.; Cash. J.D.: A radioimmunoas-say for platelet factor 4. Thromb. Res. 8: 51 (1976).
8. Moore, S.; Pepper, D.S.; Cash, J.D.: The isolation and characterisation of platelet specific β-globin (β-thromboglobulin) and the detection of anti-urokinase and anti-plasmin released from thrombin-aggregated washed human platelets. Biochim. bio-phys. Acta 379: 360 (1975).
9. Ludlam. C.A.: Evidence for the platelet specificity of β-thromboglobulin and studies on its plasma concentration in healthy individuals. Br. J. Haemat. 41: 271 (1979).
10. Doyle, D.J.; Chesterman. C.N.; Cade. J.F.: McGready. J.R.; Rennie. G.C.; Morgan. F. J.: Plasma concentrations of platelet-specific proteins correlated with platelet sur-vival. Blood 55: 82 (1980).
11. Wu. K.K.; Hoak. J.C.: A new method for the quantitative detection of platelet aggre-gates in patients with arterial insufficiency. Lancet ii: 924 (1974).
12. Celia. G.; Zahavi. J.: DeHaas, H.A.; Kakkar, V.V.:-Thromboglobulin, platelet pro-duction time and platelet function in vascular disease. Br. J. Haemat. 43: 127 (1979).
13. Ludlam, C.A.; Bolton, A.E.; Moore, S.; Cash, J.D.: New rapid method for diagnosis of deep venous thrombosis. Lancet ii: 259 (1975).
14. Burrows. A.W.; Chavin, S.I.: Hockaday, T.D.R.: Plasma β-thromboglobulin concen-trations in diabetes mellitus. Lancet i: 235 (1978).
15. Boughton. B.J.; Allington, M.J.; King. A.: Platelet and plasma β-thromboglobulin in myeloproliferative syndromas and secondary thrombocytosis. Br. J. Haemat. 40: 125 (1978).
16. Schemthaner, G.; Ludwig, H.; Silberbáuer, K.: Elevated plasma β-thromboglobulin levels in multiple myeloma and in polycythemia vεra. Acta haemal 62: 219 (1979).
17. Schemthaner. G.: Mühlhauser, I.; Silberbauer. K.: β-Thromboglobulin lowered by dipyridamole in diabetes. Lancet ii: 748 (1979).
18. Schemthaner, G.; Silberbauer, K.; Sinzinger, H.; Müller, M.: Plasma β-thromboglo-bulin and glycosylated hemoglobin (HbA1) in type I and type II diabetes meliitus. Thromb. Haemostasis 42: 334 (1979).
19. Handin. R.I.; McDonough. M.: Lesch, M.: Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J. Lab. clin. Med. 91: 340 (1978).
20. Pepper. D.S.; Ludlam, C.A.: β-Thromboglobulin (β-TG)-a new approach to the diagnosis of thrombosis: in Mills. Pareti. Platelets and thrombosis, p. 190 (Academic Press, New York 1977).
21. Witte. L.D.; Kaplan. K.L.; Nossel. H.L.; Lages, B.A.; Weiss. H.J.: Goodman. D.W.S.: Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circulation Res. 42: 402 (1978).
22. Moncada, S.: Gryglewski, R.; Bunting, S.; Vane, J.R.: An enzyme isolated from arter-ies transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. Lond. 263: 663 (1976).
23. Ludlam. C.A.; Cash, J.D.: Studies on the liberation from human platelets in vitro. Br. J. Haemat. 33: 239 (1976).
24. Rohrer. T.F.: Pfister. B.; Weber. C.; Imhof P.R.: Stucki. P.: Quantitative changes in platelet aggregation due to physiological and pathological factors and medication. Blut 36: 21 (1978).
25. Haft, J.I.; Kranz, P.D.; Albert. F.J.; Fani, K.: Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation 46: 698 (1972).
26. Haft, J.I.: Fani, K.; Alcorta, C.: Toor, M.: Effect of propranolol on stress induced intravascular platelet aggregation in the heart (Abstract). Circulation 48: suppl IV, p. 57 (1973).
27. Battler. A.; Ross. J.; Slutsky, R.; Pfisterer. M.: Ashburn. W.: Froelicher, V.: Improve-ment of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease. Am. J. Cardiol. 44: 318 (1979).
28. Prentice, C.R.M.: Long-term anticoagulant treatment. Prescribers J. 16: 116 (1976).
29. Abernathy, W.S.; Willis. P.W.: Thromboembolic complications of rheumatic heart disease. Cardiovasc. Clin. 5: 131 (1973).
30. Chalmers, T.C.: Matta. R.J.; Smith, H. Jr.: Evidence favoring the use of anticoagu-lants in the hospital phase of acute myocardial infarction. New Engl. J. Med. 297: 1091 (1977).
31. Selzer. A.: Use of anticoagulant agents in acute myocardial infarction: statistics of clinical judgement? Am. J. Cardiol. 41: 1315 (1978).
32. Ritchie. J.L.: Harker, L.A.: Platelet and fibrinogen survival in coronary atherosclero-sis. Am. J. Cardiol. 39: 595 (1977).
33. Steele. P.: Rainwater. J.: Vogel, R.: Genton. E.: Platelet-suppressant therapy in patients with coronary artery disease. J. Am. med. Ass. 240: 228 (1978).